Nian Dong

690 total citations
32 papers, 543 citations indexed

About

Nian Dong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nian Dong has authored 32 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Nian Dong's work include Neonatal Respiratory Health Research (6 papers), Air Quality and Health Impacts (4 papers) and Epigenetics and DNA Methylation (4 papers). Nian Dong is often cited by papers focused on Neonatal Respiratory Health Research (6 papers), Air Quality and Health Impacts (4 papers) and Epigenetics and DNA Methylation (4 papers). Nian Dong collaborates with scholars based in China, Germany and United States. Nian Dong's co-authors include Chengshui Chen, Xiangdong Wang, Lin Shi, Xiangdong Wang, Xiaocong Fang, Hua Diao, Heguo Yu, Menglin Xu, Diane C. Wang and Yong Zhang and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Nian Dong

30 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nian Dong China 14 308 139 113 92 65 32 543
Cinzia Cordazzo Italy 14 422 1.4× 138 1.0× 84 0.7× 90 1.0× 69 1.1× 25 685
Marianne Kjalke Denmark 21 224 0.7× 121 0.9× 69 0.6× 94 1.0× 58 0.9× 50 1.3k
Cheng Su China 16 376 1.2× 122 0.9× 116 1.0× 127 1.4× 54 0.8× 50 725
Monica Cipollini Italy 14 291 0.9× 205 1.5× 113 1.0× 166 1.8× 73 1.1× 28 709
Xiuling Li China 14 228 0.7× 82 0.6× 108 1.0× 145 1.6× 48 0.7× 29 468
Xuan Su China 16 469 1.5× 114 0.8× 119 1.1× 240 2.6× 68 1.0× 57 799
Junling Zhang China 14 216 0.7× 167 1.2× 221 2.0× 129 1.4× 71 1.1× 56 567
Yiran Li China 18 233 0.8× 97 0.7× 120 1.1× 139 1.5× 137 2.1× 44 596
Bryan M. Gillard United States 12 320 1.0× 124 0.9× 137 1.2× 111 1.2× 81 1.2× 25 615
Manar Atyah China 13 287 0.9× 117 0.8× 135 1.2× 204 2.2× 42 0.6× 27 543

Countries citing papers authored by Nian Dong

Since Specialization
Citations

This map shows the geographic impact of Nian Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nian Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nian Dong more than expected).

Fields of papers citing papers by Nian Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nian Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nian Dong. The network helps show where Nian Dong may publish in the future.

Co-authorship network of co-authors of Nian Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Nian Dong. A scholar is included among the top collaborators of Nian Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nian Dong. Nian Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yao, Qian, et al.. (2024). FGF10 protects against particulate matter-induced lung injury by inhibiting ferroptosis via Nrf2-dependent signaling. International Immunopharmacology. 134. 112165–112165. 8 indexed citations
3.
Dong, Nian, et al.. (2024). MiR-3074-5p suppresses non-small cell lung cancer progression by targeting the YWHAZ/Hsp27 axis. International Immunopharmacology. 138. 112547–112547. 2 indexed citations
5.
Chen, Junjie, Qian Yao, Yi Jin, et al.. (2023). Epithelial-mesenchymal transition is associated with osteopontin-induced EGFR-TKI resistance in EGFR mutant non-small cell lung cancer. Journal of Thoracic Disease. 15(6). 3359–3371. 3 indexed citations
6.
Liu, Li, Kankai Wang, Qian Yao, et al.. (2022). Fibroblast growth factor 10 protects against particulate matter-induced lung injury by inhibiting oxidative stress-mediated pyroptosis via the PI3K/Akt/Nrf2 signaling pathway. International Immunopharmacology. 113(Pt A). 109398–109398. 17 indexed citations
7.
Wang, Qiang, Li Liu, Junjie Chen, et al.. (2022). FGF10 protects against particulate matter (PM)-induced lung injury via regulation of endoplasmic reticulum stress. International Immunopharmacology. 105. 108552–108552. 6 indexed citations
8.
Wang, Beibei, Nian Dong, Ya Fang, et al.. (2022). Sphingosine 1-phosphate receptor 1 governs endothelial barrier function and angiogenesis by upregulating endoglin signaling. Annals of Translational Medicine. 10(3). 136–136. 10 indexed citations
9.
Wang, Kan, et al.. (2022). Comparison of Four Machine Learning Techniques for Prediction of Intensive Care Unit Length of Stay in Heart Transplantation Patients. Frontiers in Cardiovascular Medicine. 9. 863642–863642. 10 indexed citations
10.
Wang, Qiang, et al.. (2022). FGF10 mediates protective anti-oxidative effects in particulate matter-induced lung injury through Nrf2 and NF-κB signaling. Annals of Translational Medicine. 10(22). 1203–1203. 10 indexed citations
11.
Dong, Nian, et al.. (2019). Tetratrichomonas in pyopneumothorax. The American Journal of Emergency Medicine. 37(6). 1215.e1–1215.e4. 4 indexed citations
12.
Gu, Wenwen, Wenping Xu, Xiaoxi Sun, et al.. (2017). Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity. Scientific Reports. 7(1). 43940–43940. 12 indexed citations
13.
Shi, Lin, et al.. (2017). Lipopolysaccharide-induced CCN1 production enhances interleukin-6 secretion in bronchial epithelial cells. Cell Biology and Toxicology. 34(1). 39–49. 33 indexed citations
14.
Dong, Nian, et al.. (2016). The Clinical Clues of Pulmonary Alveolar Proteinosis: A Report of 11 Cases and Literature Review. Canadian Respiratory Journal. 2016. 1–5. 5 indexed citations
15.
Dong, Nian, Lin Shi, Diane C. Wang, Chengshui Chen, & Xiangdong Wang. (2016). Role of epigenetics in lung cancer heterogeneity and clinical implication. Seminars in Cell and Developmental Biology. 64. 18–25. 41 indexed citations
16.
Zhang, Yong, Jian Wang, Haiyun Wang, et al.. (2016). Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer. Cell Biology and Toxicology. 32(5). 419–435. 47 indexed citations
17.
Shi, Lin, Nian Dong, Chengshui Chen, & Xiangdong Wang. (2016). Potential roles of telocytes in lung diseases. Seminars in Cell and Developmental Biology. 55. 31–39. 16 indexed citations
18.
Pan, Jue, et al.. (2016). IL-27 attenuates airway inflammation in a mouse asthma model via the STAT1 and GADD45γ/p38 MAPK pathways. Journal of Translational Medicine. 14(1). 283–283. 21 indexed citations
19.
Hong, Hao, et al.. (2016). Results of a hybrid procedure for patients with proximal left subclavian artery stenosis and coronary artery disease. Journal of Thoracic and Cardiovascular Surgery. 152(1). 131–136. 2 indexed citations
20.
Wang, Jian, et al.. (2015). Global analyses of subtype- or stage-specific genes on chromosome 7 in patients with lung cancer. Cancer and Metastasis Reviews. 34(2). 333–345. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026